Kratom has 'deadly risks' warns FDA

The supplement kratom has "deadly risks" and might even expand the opioid epidemic, the FDA warns.

"It's very troubling to the FDA that patients believe they can use kratom to treat opioid withdrawal symptoms," FDA Commissioner Scott Gottlieb said in a statement. "There is no reliable evidence to support the use of kratom as a treatment for opioid use disorder."Instead, he said, the FDA is concerned that the use of kratom could actually "expand the opioid epidemic." "We've learned a tragic lesson from the opioid crisis: that we must pay early attention to the potential for new products to...